Allergy Research Group ®
Fibrenase III Lumbrokinase
To support the breaking up/dissolving of the
unhealthy coagulation of blood
(30 capsules - 230 mg) Lumbrokinase is an enzyme
derived from earthworms Lumbricus rubellus. Research has shown
lumbrokinase to support the body in breaking up and dissolving the
unhealthy coagulation of blood and to enhance fibrinolytic activity,
i.e. similar to nattokinase.
Lumbrokinase (LK) consists of a group of
proteolytic enzymes including plasminogen activator and plasmin
extracted from a specific species of earthworm. The plasminogen
activator (e-PA) in LK is similar to tissue plasminogen activator (t-PA)
from other sources, which makes it possible to show the thrombolytic
activity only in the presence of fibrin. Therefore, LK has the advantage
of not causing excessive bleeding. The activity of LK is much higher
than most traditional Chinese medicines that are available in the United
States. Four phases of clinical studies have been done on LK at the
Beijing Xuanwu Hospital (the top hospital in nerve & internal medicine
in China). LK has been widely used in over 100 hospitals in Beijing
since 1995. In Jakarta, LK has been used in thousands of hospitals and
drug stores in more than 20 provinces and cities as well as in Hong
Kong, Taiwan, Southeast Asia, and Europe.
LK has a certificate of GMP for human drugs from
the SDA in China and is recognized as a state class new drug approved by
the Ministry of Public Health. LK capsules technology was awarded with a
certificate of National Significance Achievement in Science and
Technology listed as the Promotional project of National Key Technology
Achievement and the National Torch Plan Program, and selected as
National Key New product by 6 major ministries. It has been included in
the Medicines Catalog of National Fundamental Health Insurance and
awarded with gold prize at China's Achievement in Medicine and Public
Health Technology Fair. *
